• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测的来自许可疫苗的 HLA I 类和 II 类表位在新的 SARS-CoV-2 关注的奥密克戎变异株中基本保守。

Predicted HLA Class I and Class II Epitopes From Licensed Vaccines Are Largely Conserved in New SARS-CoV-2 Omicron Variant of Concern.

机构信息

Presentation and Immune Regulation Unit, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Spain.

出版信息

Front Immunol. 2022 Jan 28;13:832889. doi: 10.3389/fimmu.2022.832889. eCollection 2022.

DOI:10.3389/fimmu.2022.832889
PMID:35154154
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8831693/
Abstract

The potential effect of emerging SARS-CoV-2 variants on vaccine efficacy is an issue of critical importance. In this study, the possible impact of mutations that facilitate virus escape from the cytotoxic and the helper cellular immune responses in the new SARS-CoV-2 Omicron variant of concern was analyzed for the 551 and 41 most abundant HLA class I and II alleles, respectively. Computational prediction showed that almost all of these 592 alleles, which cover 90% of the human population, contain enough epitopes without escape mutations in the emerging SARS-CoV-2 Omicron variant of concern. These data suggest that both cytotoxic and helper cellular immune protection elicited by currently licensed vaccines are virtually unaffected by the highly contagious SARS-CoV-2 Omicron variant of concern.

摘要

新型 SARS-CoV-2 变体对疫苗效力的潜在影响是一个至关重要的问题。在这项研究中,分析了新出现的 SARS-CoV-2 关注变体奥密克戎中有助于病毒逃避细胞毒性和辅助性细胞免疫反应的突变对 551 个和 41 个最丰富的 HLA Ⅰ类和Ⅱ类等位基因的可能影响。计算预测表明,这些涵盖 90%人口的 592 个等位基因中,几乎所有的等位基因都含有足够的表位,而在新出现的 SARS-CoV-2 关注变体奥密克戎中没有逃逸突变。这些数据表明,目前授权的疫苗所引起的细胞毒性和辅助性细胞免疫保护几乎不受高传染性的 SARS-CoV-2 关注变体奥密克戎的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cad9/8831693/ebf3615d0a6a/fimmu-13-832889-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cad9/8831693/db56ae8a10aa/fimmu-13-832889-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cad9/8831693/ebf3615d0a6a/fimmu-13-832889-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cad9/8831693/db56ae8a10aa/fimmu-13-832889-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cad9/8831693/ebf3615d0a6a/fimmu-13-832889-g002.jpg

相似文献

1
Predicted HLA Class I and Class II Epitopes From Licensed Vaccines Are Largely Conserved in New SARS-CoV-2 Omicron Variant of Concern.预测的来自许可疫苗的 HLA I 类和 II 类表位在新的 SARS-CoV-2 关注的奥密克戎变异株中基本保守。
Front Immunol. 2022 Jan 28;13:832889. doi: 10.3389/fimmu.2022.832889. eCollection 2022.
2
Predicted Epitope Abundance Supports Vaccine-Induced Cytotoxic Protection Against SARS-CoV-2 Variants of Concern.预测的表位丰度支持针对 SARS-CoV-2 关切变异株的疫苗诱导的细胞毒性保护。
Front Immunol. 2021 Nov 25;12:732693. doi: 10.3389/fimmu.2021.732693. eCollection 2021.
3
COVID-19 coronavirus vaccine T cell epitope prediction analysis based on distributions of HLA class I loci (HLA-A, -B, -C) across global populations.基于全球人群中 HLA Ⅰ类基因座(HLA-A、-B、-C)分布的 COVID-19 冠状病毒疫苗 T 细胞表位预测分析。
Hum Vaccin Immunother. 2021 Apr 3;17(4):1097-1108. doi: 10.1080/21645515.2020.1823777. Epub 2020 Nov 11.
4
Differential epitope prediction across diverse circulating variants of SARS-COV-2 in Brazil.巴西不同循环 SARS-CoV-2 变体的差异表位预测。
Comput Biol Chem. 2024 Oct;112:108139. doi: 10.1016/j.compbiolchem.2024.108139. Epub 2024 Jun 29.
5
Immuno-informatics design of a multimeric epitope peptide based vaccine targeting SARS-CoV-2 spike glycoprotein.基于 SARS-CoV-2 刺突糖蛋白的多聚表位肽疫苗的免疫信息学设计。
PLoS One. 2021 Mar 17;16(3):e0248061. doi: 10.1371/journal.pone.0248061. eCollection 2021.
6
SARS-CoV-2 Omicron BA.4/BA.5 Mutations in Spike Leading to T Cell Escape in Recently Vaccinated Individuals.新冠病毒奥密克戎变异株 BA.4/BA.5 刺突突变导致近期接种疫苗个体 T 细胞逃逸。
Viruses. 2022 Dec 29;15(1):101. doi: 10.3390/v15010101.
7
Minimal Crossover between Mutations Associated with Omicron Variant of SARS-CoV-2 and CD8 T-Cell Epitopes Identified in COVID-19 Convalescent Individuals.在 COVID-19 康复个体中鉴定的与 SARS-CoV-2 的奥密克戎变异株相关的突变和 CD8 T 细胞表位之间最小交叉。
mBio. 2022 Apr 26;13(2):e0361721. doi: 10.1128/mbio.03617-21. Epub 2022 Mar 1.
8
Mapping the immunopeptidome of seven SARS-CoV-2 antigens across common HLA haplotypes.绘制七种 SARS-CoV-2 抗原在常见 HLA 单倍型上的免疫肽组图谱。
Nat Commun. 2024 Aug 30;15(1):7547. doi: 10.1038/s41467-024-51959-6.
9
Omicron BA.1 Mutations in SARS-CoV-2 Spike Lead to Reduced T-Cell Response in Vaccinated and Convalescent Individuals.奥密克戎 BA.1 突变使 SARS-CoV-2 刺突蛋白减少,导致接种疫苗和康复个体的 T 细胞反应降低。
Viruses. 2022 Jul 19;14(7):1570. doi: 10.3390/v14071570.
10
Conservation of HLA Spike Protein Epitopes Supports T Cell Cross-Protection in SARS-CoV-2 Vaccinated Individuals against the Potentially Zoonotic Coronavirus Khosta-2.HLA 棘突蛋白表位的保守性支持 SARS-CoV-2 疫苗接种个体对潜在人畜共患冠状病毒 Khosta-2 的 T 细胞交叉保护作用。
Int J Mol Sci. 2024 May 31;25(11):6087. doi: 10.3390/ijms25116087.

引用本文的文献

1
Mosaic vaccine design targeting mutational spike protein of SAR-SCoV-2: An immunoinformatics approach.针对新型冠状病毒(SARS-CoV-2)突变刺突蛋白的嵌合疫苗设计:一种免疫信息学方法。
Bioimpacts. 2024 Apr 22;15:26443. doi: 10.34172/bi.2023.26443. eCollection 2025.
2
Bioinformatic Tools for Studying the Cellular Immune Response to SARS-CoV-2, Vaccine Efficacy, and Future Pandemics at the Global Population Level.用于在全球人群层面研究针对SARS-CoV-2的细胞免疫反应、疫苗效力及未来大流行的生物信息学工具。
Int J Mol Sci. 2024 Dec 16;25(24):13477. doi: 10.3390/ijms252413477.
3
Conservation of HLA Spike Protein Epitopes Supports T Cell Cross-Protection in SARS-CoV-2 Vaccinated Individuals against the Potentially Zoonotic Coronavirus Khosta-2.

本文引用的文献

1
Predicted Epitope Abundance Supports Vaccine-Induced Cytotoxic Protection Against SARS-CoV-2 Variants of Concern.预测的表位丰度支持针对 SARS-CoV-2 关切变异株的疫苗诱导的细胞毒性保护。
Front Immunol. 2021 Nov 25;12:732693. doi: 10.3389/fimmu.2021.732693. eCollection 2021.
2
SARS-CoV-2 variants, spike mutations and immune escape.SARS-CoV-2 变体、刺突突变和免疫逃逸。
Nat Rev Microbiol. 2021 Jul;19(7):409-424. doi: 10.1038/s41579-021-00573-0. Epub 2021 Jun 1.
3
Emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States.
HLA 棘突蛋白表位的保守性支持 SARS-CoV-2 疫苗接种个体对潜在人畜共患冠状病毒 Khosta-2 的 T 细胞交叉保护作用。
Int J Mol Sci. 2024 May 31;25(11):6087. doi: 10.3390/ijms25116087.
4
Could SARS-CoV-1 Vaccines in the Pipeline Have Contributed to Fighting the COVID-19 Pandemic? Lessons for the Next Coronavirus Plague.正在研发中的严重急性呼吸综合征冠状病毒1(SARS-CoV-1)疫苗是否有助于抗击新冠疫情?对下一次冠状病毒疫情的启示。
Biomedicines. 2023 Dec 27;12(1):62. doi: 10.3390/biomedicines12010062.
5
Defending against SARS-CoV-2: The T cell perspective.抵御 SARS-CoV-2:T 细胞视角。
Front Immunol. 2023 Jan 27;14:1107803. doi: 10.3389/fimmu.2023.1107803. eCollection 2023.
6
Prediction of Conserved HLA Class I and Class II Epitopes from SARS-CoV-2 Licensed Vaccines Supports T-Cell Cross-Protection against SARS-CoV-1.从新冠病毒授权疫苗预测保守的 HLA I 类和 II 类表位支持针对 SARS-CoV-1 的 T 细胞交叉保护。
Biomedicines. 2022 Jul 7;10(7):1622. doi: 10.3390/biomedicines10071622.
美国出现并迅速传播 SARS-CoV-2 变异株 B.1.1.7。
Cell. 2021 May 13;184(10):2587-2594.e7. doi: 10.1016/j.cell.2021.03.052. Epub 2021 Mar 30.
4
Genomic characterization of a novel SARS-CoV-2 lineage from Rio de Janeiro, Brazil.来自巴西里约热内卢的新型严重急性呼吸综合征冠状病毒2(SARS-CoV-2)谱系的基因组特征分析
J Virol. 2021 Apr 26;95(10). doi: 10.1128/JVI.00119-21. Epub 2021 Mar 1.
5
Sixteen novel lineages of SARS-CoV-2 in South Africa.南非出现 16 种新型 SARS-CoV-2 谱系。
Nat Med. 2021 Mar;27(3):440-446. doi: 10.1038/s41591-021-01255-3. Epub 2021 Feb 2.
6
Evidence of SARS-CoV-2 re-infection with a different genotype.新型冠状病毒 2 型(SARS-CoV-2)再次感染不同基因型的证据。
J Infect. 2021 Apr;82(4):84-123. doi: 10.1016/j.jinf.2020.11.011. Epub 2020 Nov 15.
7
COVID-19 vaccine BNT162b1 elicits human antibody and T1 T cell responses.COVID-19 疫苗 BNT162b1 可引发人体抗体和 T1 T 细胞应答。
Nature. 2020 Oct;586(7830):594-599. doi: 10.1038/s41586-020-2814-7. Epub 2020 Sep 30.
8
Immunological considerations for COVID-19 vaccine strategies.针对 COVID-19 疫苗策略的免疫学考虑。
Nat Rev Immunol. 2020 Oct;20(10):615-632. doi: 10.1038/s41577-020-00434-6. Epub 2020 Sep 4.
9
NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data.NetMHCpan-4.1 和 NetMHCIIpan-4.0:通过同时对基序进行分解以及整合 MS MHC 洗脱配体数据,改进了 MHC 抗原呈递的预测。
Nucleic Acids Res. 2020 Jul 2;48(W1):W449-W454. doi: 10.1093/nar/gkaa379.
10
IPD-IMGT/HLA Database.免疫球蛋白基因和人类白细胞抗原数据库。
Nucleic Acids Res. 2020 Jan 8;48(D1):D948-D955. doi: 10.1093/nar/gkz950.